New York, NY, United States of America

Peter Kotanko

This inventor holds 55 USPTO granted patents and 32 published patent applications, plus 13 CIPO patents and 22 EPO patents, primarily in Dialysis Techniques. Top assignees: Fresenius Medical Care Holdings, Inc., Fresenius Medical Care Deutschland Gmbh, Fresenius Medical Care Ag & Co Kgaa. Active years: 2012-2026.

USPTO Granted Patents = 55 

% Patents Active = 96.4

 

 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 161(Granted Patents)

Forward Citations (Not Self Cited) = 137(Dec 10, 2025)


Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Dialysis
Fluid Volume Monitoring
Patient Profiling
Toxin Displacer Optimization
Chronic Kidney Disease
Bioimpedance
Intradialytic Monitoring
Virtual Clinical Trials
Hemodynamic Status
Access Recirculation
Vascular Access
Oxygen Dosing
55 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Peter Kotanko in Medical Technology**

Introduction

Peter Kotanko is a prominent inventor based in New York, NY, with a remarkable portfolio of 48 patents. His work primarily focuses on advancements in medical technology, particularly in the field of dialysis treatment and infectious disease mitigation. His innovative approaches have provided significant contributions to improving patient care and medical analysis.

Latest Patents

Among his latest inventions, Kotanko has developed a "System for assessing and mitigating potential spread of infectious disease among dialysis patients". This groundbreaking method involves a prediction system that integrates individual treatment data and lab data to determine disease analysis results, helping medical facilities to take informed actions to prevent the spread of infections.

Another notable patent is the "Systems and methods for analyzing spent dialysate". This apparatus utilizes a specialized configuration to analyze spent dialysate effectively, enhancing the accuracy of dialysis treatment evaluations through advanced light sensing technology.

Career Highlights

Throughout his career, Peter Kotanko has been associated with esteemed organizations such as Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care Deutschland Gmbh. His involvement in these companies has allowed him to apply his research in practical settings, thereby influencing the standards of patient care in cardiology and nephrology.

Collaborations

Kotanko has partnered with noteworthy colleagues, including Stephan Thijssen and Nathan W. Levin. Together, they have worked on multiple projects that push the boundaries of medical technology, striving to create solutions that enhance patient outcomes in treatment facilities.

Conclusion

Peter Kotanko's contributions to medical innovations, particularly in the area of dialysis treatment and infectious disease management, demonstrate his commitment to improving healthcare technologies. With an extensive portfolio of patents, his inventions not only provide immediate benefits to patients but also pave the way for future advancements in medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…